Skip to main content

Clinical Trials › NCT06396039

Active, Not RecruitingPhase 4

A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis

Sponsored by Bristol-Myers Squibb

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
84
Target enrollment
May 2024
Start date
Mar 2029
Expected completion

Interventions / Treatments

BMS-986374

Conditions studied

Relapsing Multiple Sclerosis

Trial locations

U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.

More Phase 4 trials

Browse all Phase 4 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play